
Anthropic's new AI model, Claude Fable 5, is restricted from answering basic biology questions due to safety concerns about potential misuse in bioweapons research, despite its advanced capabilities in other scientific fields.
AI-generated summary
Anthropic just released Claude Fable 5, calling it the most powerful AI model it has ever made widely available and praising its skills in biology, among others. But the model wonât answer basic biology questions â the kind youâd expect a high schooler to handle. Instead, it hands off the query to the former flagship model, Claude Opus 4.8.
It isnât because Fable doesnât know the answers. Itâs because Anthropic wonât let it, by design.
Fable is a public-facing, Mythos-class model, a family so capable at cybersecurity tasks Anthropic said it was too dangerous to release publicly. But while Anthropic has spent much of the extended Mythos rollout warning about cybersecurity, it is biology where Fableâs guardrails are the most obvious â and most limiting.
When I tried the model, it refused to answer a range of basic biology questions, many that felt about as far away from any plausible safety risk as any question could be. It would not respond to âtell me about cell membranesâ or answer âwhat are mitochondria,â that famous powerhouse of the cell. It refused to explain âwhat is a prion,â the proteinaceous particles behind mad cow disease, or âhow mRNA vaccines work.â
The restrictions applied to ordinary and objectively rather harmless medical queries too. Fable would not answer âwhat causes hay fever,â explain how asthma medicine works, explain how antibiotic resistance arises, or tell me what Ebola is and how it spreads. Some of my basic queries occasionally got through, with Fable answering questions like âwhat is cancerâ and âwhat is DNA.â When Fable refused, Opus 4.8 generally answered perfectly well.
Anthropic says the broad biology filters are an intentional choice and are deliberately conservative, with bioweapons the primary concern. âWith the launch of Claude Fable 5, our first Mythos-class model, we believe models now have a greater ability to accomplish real-world scientific tasks and for malicious actors to potentially use our models for highly risky biological research,â spokesperson Paruul Maheshwary told The Verge. âWe have always used classifiers to block our models from helping with bioweapons-related requests. To deploy Fable 5 safely, we believe it was necessary to be overly conservative with our safeguards so they block most queries tied to biology work.â
Anthropic has previously highlighted four key areas where it would throttle Fableâs responses for safety: chemistry, biology, cybersecurity, and distillation, a technique for training smaller AIs using the outputs of larger ones. The company has accused Chinese rivals like DeepSeek of using distillation on its models on an âindustrialâ scale.
While I could not meaningfully test distillation, Fable seemed more willing to answer questions about chemistry and cybersecurity. For example, it gave a basic overview of the explosive TNT, though withheld synthesis instructions âfor obvious reasons.â It readily answered questions on the use of chlorine gas as a chemical weapon, common password threats, and nuclear fusion and fission, as well as explaining how to secure an iPhone from hackers. It still limits: Fable deferred to Opus when I asked it about sarin gas, a highly toxic nerve agent. Fable and Opus both refused the prompt âhow to make anthrax,â and Claude paused the chat entirely. That made sense. The mitochondria prompt refusal seems like a false positive.
âWe made this tradeoff so customers could benefit from the modelâs capabilities sooner without the risks,â Maheshwary explained, adding that Anthropic is working hard to improve its detection and reduce the false positives. âWe intend to make Mythos-class models available without these safeguards to the broader biology and life sciences community so these capabilities can be used to accelerate biomedical research and drug discovery.â
Anthropic did not answer questions about whether this kind of restricted release will become the new norm for future models.

The Pebble Time 2, a rebooted indie smartwatch by founder Eric Migicovsky and Core Devices, offers a retro-inspired, community-driven alternative to mainstream smartwatches with its e-paper display, long battery life, and extensive library of user-created apps.

Michael Polansky, co-founder of Outer Biosciences, is emerging from years of stealth to discuss his startup's AI-driven approach to dermatology. The company uses living human skin tissue to test cosmetic and pharmaceutical ingredients, aiming to accelerate discovery.

Sapporo-based startup Letara has raised „2.6 billion ($16 million) to scale its hybrid rocket propulsion technology. The company, which spun out of Hokkaido University, aims to supply satellite makers, launch companies, and defense sectors with its proprietary systems.

As Meta AI glasses gain popularity, concerns over nonconsensual recording have led to bans in public venues and the rise of hobbyist-developed detection apps. These tools use Bluetooth signals to help people identify nearby smart glasses, though they remain imperfect solutions.

TikTok has reached a settlement regarding COPPA violations, described as one of the largest recoveries in the history of such cases.

Nvidia research reveals that software wrappers or 'harnesses' surrounding AI models are more crucial than the underlying model itself for long-horizon tasks, allowing Claude Opus 5 to score 100% on the ARC-AGI-3 benchmark.